SCHEMBL23606728

SCHEMBL23606728

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4nc5ccccc5nc4-c4cccc(-c5nc6ccccc6s5)c4)c3)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.57
▸ KDM4E B2RXH2 9/20 0.57
▸ SMN1; SMN2 Q16637 6/20 0.57
▸ MAPT P10636 6/20 0.57
▸ NPC1 O15118 6/20 0.57
▸ NFKB1 P19838 5/20 0.57
▸ NFKB2 Q00653 5/20 0.57
▸ RELA Q04206 5/20 0.57
▸ ALDH1A1 P00352 5/20 0.57
▸ LMNA P02545 4/20 0.57
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ HSD17B10 Q99714 3/20 0.57
▸ TP53 P04637 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ TDP1 Q9NUW8 2/20 0.53
▸ APP P05067 4/20 0.51
▸ MMP9 P14780 1/20 0.50
▸ MMP8 P22894 1/20 0.50
▸ GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19369706 0.93 RAB9A (0.65) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL27049348 0.87 RAB9A (0.61) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL23606715 0.87 APP (0.62) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL27049351 0.86 APP (0.60) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL18308532 0.85 KDM4E (0.63) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL19846139 0.84 APP (0.58) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL27258689 0.83 APP (0.54) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL5461064 0.83 RAB9A (0.77) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL13068071 0.83 APP (0.55) RAB9AKDM4ESMN1; SMN2MAPTNPC1
SCHEMBL19846143 0.83 APP (0.57) RAB9AKDM4ESMN1; SMN2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198212-A1 ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2021-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198212-A1 ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DISPLAY DEVICE USING THE SAME OCIAD2, OCIAD1, TRPC1 RAB9A 4144/4885KDM4E 3625/4885SMN1; SMN2 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback